Ulcerative colitis has no cure. The chronic inflammatory bowel disease affects the lining of the colon and causes abdominal pain, persistent diarrhea and fatigue that can substantially reduce quality of life. As of 2019, roughly 4.9 million people worldwide were living with inflammatory bowel disease, a category that includes both ulcerative colitis and Crohn’s disease. Existing treatments manage symptoms to varying degrees but carry significant side effects and do not work equally well for all patients.
A new study published in the Journal of the Science of Food and Agriculture examines whether extract from the Mediterranean strawberry tree, known scientifically as Arbutus unedo, could offer a natural complement or alternative to those treatments. The early results, drawn from an animal model, are more encouraging than typical early-stage research.
What the study tested and what it found
Researchers led by a team from the Higher Institute of Biotechnology of Beja in Tunisia used a mouse model to test the extract’s protective effects. Mice were given doses of the strawberry tree extract before being exposed to a chemical that induces ulcerative colitis. The group pretreated with the extract showed significant protection against damage to the colon lining compared to the control group that did not receive it.
The pretreated mice also developed fewer colonic lesions and showed reduced expression of proteins associated with oxidative stress and inflammation. Those two mechanisms, oxidative damage and inflammatory response, are central to how ulcerative colitis progresses and causes tissue damage over time.
The study builds on earlier research that identified antioxidant and anti-inflammatory properties in Arbutus unedo. The new findings extend that work by testing those properties directly against an induced colitis model rather than measuring them in isolation.
Why the findings matter and what they do not yet prove
Animal studies occupy an early and limited position in the research pipeline. Results that hold in mice frequently do not replicate in human clinical trials, and the conditions of an induced mouse model do not perfectly reflect the complexity of chronic human disease. The researchers and outside experts commenting on the work have been careful to frame the findings as preliminary rather than conclusive.
What the study does provide is a mechanistic basis for further investigation. The fact that the extract reduced specific inflammatory and oxidative stress markers, rather than simply showing a general protective effect, gives researchers clearer targets to examine in follow-up studies. That specificity strengthens the case for moving toward human trials rather than treating the findings as a curiosity.
Current treatments for ulcerative colitis, which include anti-inflammatory medications, immune system suppressors and in severe cases surgery, can be effective but are often expensive and produce side effects significant enough that some patients discontinue them. A natural compound that demonstrated safety and comparable efficacy in human trials would represent a meaningful addition to the treatment landscape.
What people with colitis can do now
The strawberry tree is native to the Mediterranean region and not widely accessible as a food or supplement in most parts of the world. For people living with ulcerative colitis who are interested in dietary approaches to managing inflammation, registered dietitians generally point toward foods high in antioxidants and anti-inflammatory compounds as a supportive strategy alongside medical treatment.
Foods containing glutathione, a compound involved in cellular defense against oxidative stress, include asparagus, avocados, broccoli and spinach. Polyphenols, which have demonstrated anti-inflammatory properties in research, are found in grapes, green tea, turmeric and apples. Glutamine, an amino acid that supports intestinal lining integrity, appears in beans, cabbage, eggs and fish.
None of these dietary approaches replaces prescribed treatment for active ulcerative colitis, and individual responses vary significantly depending on disease severity and other health factors. The strawberry tree research, if it advances to human trials, would eventually add another data point to a field that is still working out which natural compounds can move from promising to proven.
